| MeSH term | MeSH ID | Detail |
|---|---|---|
| Mandibular Diseases | D008336 | 5 associated lipids |
| Bone Resorption | D001862 | 7 associated lipids |
| Foreign-Body Reaction | D005549 | 10 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Arthritis, Experimental | D001169 | 24 associated lipids |
| Bone Neoplasms | D001859 | 5 associated lipids |
| Fractures, Bone | D050723 | 4 associated lipids |
| Osteoarthritis | D010003 | 4 associated lipids |
| Carcinoma | D002277 | 18 associated lipids |
| Osteonecrosis | D010020 | 5 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Corey E et al. | Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. | 2002 | Prostate | pmid:11992617 |
| Hesry V et al. | Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. | 2006 | Prostate | pmid:16541419 |
| Eaton CL et al. | Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer. | 2004 | Prostate | pmid:15042606 |
| Helo S et al. | Role of denosumab in prostate cancer. | 2012 | Prostate Cancer Prostatic Dis. | pmid:22370723 |
| Quinn JE et al. | Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms. | 2005 | Prostate Cancer Prostatic Dis. | pmid:15999121 |
| Vandyke K et al. | Androgen decreases osteoprotegerin expression in prostate cancer cells. | 2007 | Prostate Cancer Prostatic Dis. | pmid:17189957 |
| Liu Z et al. | Production of recombinant human osteoprotegrin from Trichoplusia ni cells and Bombyx mori larvae. | 2004 | Protein Pept. Lett. | pmid:15327363 |
| Janda K et al. | [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. | 2012 | Prz. Lek. | pmid:23750431 |
| Czyzewska-Buczyńska A et al. | [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients]. | 2013 | Prz. Lek. | pmid:24003660 |
| Ziółkowska H and Roszkowska-Blaim M | [Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure]. | 2006 | Prz. Lek. | pmid:16898492 |
| Komosińska-Vassev K et al. | [Osteoporosis--pathophysiology and laboratory diagnostic methods]. | 2010 | Prz. Lek. | pmid:21387765 |
| Kahl KG et al. | Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. | 2006 Sep-Oct | Psychosom Med | pmid:17012519 |
| Minenna G et al. | [RANKL/RANK, OPG and OPT in a group of patients affected by chronic arthritis. Preliminary report]. | 2005 | Recenti Prog Med | pmid:16229324 |
| Heymann MF et al. | OPG, RANK and RANK ligand expression in thyroid lesions. | 2008 | Regul. Pept. | pmid:18367263 |
| Kadoglou NP et al. | Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. | 2012 | Regul. Pept. | pmid:22982141 |
| Crisafulli A et al. | Osteoprotegerin and bone mineral density in hemodiafiltration patients. | 2005 | Ren Fail | pmid:16152990 |
| Pobeha P et al. | Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD. | 2014 | Respir Med | pmid:24424018 |
| Bai P et al. | Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. | 2011 | Respir. Res. | pmid:22176920 |
| Bogliolo L et al. | Biomarkers and prognostic stratification in psoriatic arthritis. | 2012 | Reumatismo | pmid:22690385 |
| Riancho JA and Delgado-Calle J | [Osteoblast-osteoclast interaction mechanisms]. | 2011 | Reumatol Clin | pmid:21924211 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Collantes Estévez E and González DomÃnguez J | [Bone Paget's disease in the young adult]. | 2004 | Rev Clin Esp | pmid:15456600 |
| Ciacli C et al. | [Bone turnover markers evaluation in psoriatic arthritis]. | 2008 Jul-Sep | Rev Med Chir Soc Med Nat Iasi | pmid:20201244 |
| Rosa-Rañal M et al. | [New paradigms in the regulation of bone metabolism]. | 2001 Jul-Aug | Rev. Invest. Clin. | pmid:11599485 |
| Xu S et al. | Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. | 2012 | Rheumatol. Int. | pmid:22057136 |
| Skoumal M et al. | The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis. | 2008 | Rheumatol. Int. | pmid:18075741 |
| Kanbe K et al. | Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:21789615 |
| Oelzner P et al. | The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:20821212 |
| Rooney T et al. | Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. | 2010 | Rheumatol. Int. | pmid:19847430 |
| Hein GE et al. | sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis. | 2008 | Rheumatol. Int. | pmid:18172654 |
| Stupphann D et al. | Intracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis. | 2008 | Rheumatol. Int. | pmid:18369625 |
| Yun HJ et al. | Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha. | 2009 | Rheumatol. Int. | pmid:19116717 |
| Agarwal S et al. | Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. | 2009 | Rheumatol. Int. | pmid:19052752 |
| Zhou J et al. | Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats. | 2013 | Rheumatol. Int. | pmid:22948539 |
| Keller KK et al. | SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. | 2013 | Rheumatol. Int. | pmid:22948540 |
| Skoumal M et al. | Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. | 2005 | Rheumatol. Int. | pmid:15889303 |
| Yao Y et al. | Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. | 2013 | Rheumatol. Int. | pmid:23334376 |
| Pamuk BO et al. | Evaluation of circulating endothelial biomarkers in familial Mediterranean fever. | 2013 | Rheumatol. Int. | pmid:23358733 |
| Chen J et al. | OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. | 2012 | Rheumatol. Int. | pmid:22210270 |
| Kwon SR et al. | Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. | 2012 | Rheumatol. Int. | pmid:21833531 |
| Upton AR et al. | The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. | 2012 | Rheumatol. Int. | pmid:21259010 |
| Haynes DR et al. | Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. | 2001 | Rheumatology (Oxford) | pmid:11426018 |
| Kim HR et al. | Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). | 2006 | Rheumatology (Oxford) | pmid:16567356 |
| Corallini F et al. | The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. | 2009 | Rheumatology (Oxford) | pmid:19168833 |
| Smith MD | Comment on review on T cells in bone biology. | 2004 | Rheumatology (Oxford) | pmid:15448222 |
| Pettit AR et al. | RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. | 2006 | Rheumatology (Oxford) | pmid:16490750 |
| Bezerra MC et al. | Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. | 2005 | Rheumatology (Oxford) | pmid:16219645 |
| Kwan Tat S et al. | Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. | 2009 | Rheumatology (Oxford) | pmid:19762475 |
| Castellino G et al. | The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? | 2010 | Rheumatology (Oxford) | pmid:20299382 |
| Varsani H et al. | Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK). | 2003 | Rheumatology (Oxford) | pmid:12649407 |
| Engvall IL et al. | Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. | 2013 | Rheumatology (Oxford) | pmid:23275387 |
| Huang CH et al. | Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. | 2011 | Rheumatology (Oxford) | pmid:20974615 |
| Hofbauer LC et al. | Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. | 2006 | Rheumatology (Oxford) | pmid:16574701 |
| Breland UM et al. | Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. | 2010 | Rheumatology (Oxford) | pmid:20231178 |
| Haynes DR et al. | Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. | 2003 | Rheumatology (Oxford) | pmid:12509625 |
| Harashima SI et al. | Osteoprotegerin and receptor activator of nuclear factor kappaB ligand expression in fibroblast-like synoviocytes from rheumatoid arthritis and osteoarthritis patients. | 2004 | Rheumatology (Oxford) | pmid:14963213 |
| Fukagawa M et al. | [PTH and bone metabolism in chronic dialysis patients]. | 2001 | Rinsho Byori | pmid:11307321 |
| Grzegorzewska AE and MÅ‚ot M | Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15631341 |
| Grzegorzewska AE and MÅ‚ot M | Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15631342 |
| Naumnik W et al. | Serum levels of osteoprotegerin (OPG) and pro gastrin releasing peptide (ProGRP) during chemotherapy of lung cancer. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15638385 |
| Grigorie D et al. | Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis. | 2003 | Rom J Intern Med | pmid:15526523 |
| Gurban CV and Mederle O | The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. | 2011 | Rom J Morphol Embryol | pmid:22119834 |
| Takayanagi H | [Crosstalk between the immune and skeletal system]. | 2003 | Ryumachi | pmid:14598653 |
| Mohamed GB and Abdel-Latif EA | Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. | 2011 | Saudi J Kidney Dis Transpl | pmid:21912025 |
| Stenman UH et al. | Prognostic value of serum markers for prostate cancer. | 2005 | Scand J Urol Nephrol Suppl | pmid:16019759 |
| Hosbond SE et al. | Osteoprotegerin as a marker of atherosclerosis: a systematic update. | 2012 | Scand. Cardiovasc. J. | pmid:22506827 |
| Yilmaz Y et al. | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20942739 |
| Grauslund J et al. | Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20205614 |
| Bjerre M et al. | Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. | 2014 | Scand. J. Clin. Lab. Invest. | pmid:25026506 |
| Sennels HP et al. | Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. | 2007 | Scand. J. Clin. Lab. Invest. | pmid:17852826 |
| Knudsen ST et al. | Plasma concentrations of osteoprotegerin during normo- and hyperglycaemic clamping. | 2007 | Scand. J. Clin. Lab. Invest. | pmid:17365993 |
| Altinova AE et al. | Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. | 2011 | Scand. J. Clin. Lab. Invest. | pmid:21486111 |
| Muñoz-Calvo MT et al. | Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa. | 2007 | Scand. J. Clin. Lab. Invest. | pmid:17558893 |
| Reenaers C et al. | Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease. | 2008 | Scand. J. Gastroenterol. | pmid:18942021 |
| Gehrke T et al. | Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. | 2003 | Scand. J. Rheumatol. | pmid:14690142 |
| Spelling P et al. | Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? | 2008 Nov-Dec | Scand. J. Rheumatol. | pmid:18802807 |
| Sennels H et al. | Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. | 2008 Jul-Aug | Scand. J. Rheumatol. | pmid:18612923 |
| Feuerherm AJ et al. | Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. | 2001 | Scand. J. Rheumatol. | pmid:11578019 |
| Hope S et al. | Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. | 2013 | Schizophr. Res. | pmid:23403415 |
| Dieset I et al. | Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. | 2012 | Schizophr. Res. | pmid:22817875 |
| Zang L et al. | The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. | 2015 | Sci Rep | pmid:26671549 |
| Schiro A et al. | Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. | 2015 | Sci Rep | pmid:26564003 |
| Mizuno M et al. | Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. | 2015 | Sci Rep | pmid:26561427 |
| Nemeth ZK et al. | Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. | 2015 | Sci Rep | pmid:26459001 |
| Wang B et al. | Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. | 2015 | Sci Rep | pmid:26329493 |
| Kao SY and Stankovic KM | Transactivation of human osteoprotegerin promoter by GATA-3. | 2015 | Sci Rep | pmid:26216189 |
| Warren JT et al. | Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. | 2014 | Sci Signal | pmid:25140055 |
| Teitelbaum SL | Bone resorption by osteoclasts. | 2000 | Science | pmid:10968780 |
| Wickelgren I | Mining the genome for drugs. | 1999 | Science | pmid:10475849 |
| Yang X et al. | Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. | 2015 | ScientificWorldJournal | pmid:25685846 |
| Zhang Q et al. | Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. | 2013 | ScientificWorldJournal | pmid:24222748 |
| Yasuda H | [A new paradigm of osteoclast biology: discovery of OCIF and ODF]. | 2000 | Seikagaku | pmid:10967683 |
| Takayanagi H | [Signaling mechanism in the regulation of osteoclast differentiation by the immune system]. | 2003 | Seikagaku | pmid:14748148 |
| Schlieper G et al. | Inhibitors of calcification in blood and urine. | 2007 Mar-Apr | Semin Dial | pmid:17374084 |
| Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
| Josson S et al. | Tumor-stroma co-evolution in prostate cancer progression and metastasis. | 2010 | Semin. Cell Dev. Biol. | pmid:19948237 |
| Wang AY | Consequences of chronic inflammation in peritoneal dialysis. | 2011 | Semin. Nephrol. | pmid:21439430 |
| Hruska KA et al. | Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. | 2004 | Semin. Nephrol. | pmid:14730507 |
| Hortobagyi GN | Novel approaches to the management of bone metastases. | 2003 | Semin. Oncol. | pmid:14613037 |
| Berenson JR | Advances in the biology and treatment of myeloma bone disease. | 2002 | Semin. Oncol. | pmid:12520479 |